Literature DB >> 30268501

Generation of and characterization of anti-IL-11 antibodies using newly established Il11-deficient mice.

Yutaka Deguchi1, Takashi Nishina2, Kenichi Asano3, Masaki Ohmuraya4, Yoshiko Nakagawa5, Naomi Nakagata5, Tetsushi Sakuma6, Takashi Yamamoto6, Kimi Araki7, Tetuo Mikami8, Masato Tanaka3, Hiroyasu Nakano9.   

Abstract

Interleukin (IL)-11 belongs to the members of the IL-6 family of cytokines and is involved in a variety of biological responses, including hematopoiesis, bone development, and carcinogenesis. However, the cellular sources of IL-11 and regulation of IL-11 expression under physiological and pathological conditions are not fully understood. One of the causes to prevent characterization of IL-11 in vivo is due to the lack of reliable antibodies that detect IL-11 by immunohistochemistry. Moreover, although mice lacking Il11ra have been generated and extensively characterized, Il11-deficient mice have not been characterized yet. Here we generated two anti-IL-11 antibodies that blocked biological activities of IL-11 and detected IL-11 by immunohistochemistry, respectively. One clone of anti-IL-11 antibodies blocked IL-11-, but not IL-6-induced cell proliferation and IL-11-induced phosphorylation of STAT3 of an IL-11-dependent cell line. Moreover, we used recently established Il11-deficient mice to test the specificity of anti-IL-11 antibodies for immunohistochemistry. Another clone of anti-IL-11 antibodies stained stromal cells surrounding tumors of the colon of wild-type, but not Il11-deficient mice following treatment with Azoxymethane plus dextran sulfate sodium. Together, these newly developed anti-IL-11 antibodies provide a better understanding of the functions of IL-11 in vivo under various physiological and pathological conditions.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR-Cas9; Interleukin 11; Knockout mice; Proliferation; STAT3

Mesh:

Substances:

Year:  2018        PMID: 30268501     DOI: 10.1016/j.bbrc.2018.09.128

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Interleukin-11-expressing fibroblasts have a unique gene signature correlated with poor prognosis of colorectal cancer.

Authors:  Takashi Nishina; Yutaka Deguchi; Daisuke Ohshima; Wakami Takeda; Masato Ohtsuka; Shigeyuki Shichino; Satoshi Ueha; Soh Yamazaki; Mika Kawauchi; Eri Nakamura; Chiharu Nishiyama; Yuko Kojima; Satomi Adachi-Akahane; Mizuho Hasegawa; Mizuho Nakayama; Masanobu Oshima; Hideo Yagita; Kazutoshi Shibuya; Tetuo Mikami; Naohiro Inohara; Kouji Matsushima; Norihiro Tada; Hiroyasu Nakano
Journal:  Nat Commun       Date:  2021-04-16       Impact factor: 14.919

Review 2.  Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11.

Authors:  Riley D Metcalfe; Tracy L Putoczki; Michael D W Griffin
Journal:  Front Immunol       Date:  2020-07-16       Impact factor: 7.561

3.  Similarities and differences between IL11 and IL11RA1 knockout mice for lung fibro-inflammation, fertility and craniosynostosis.

Authors:  Benjamin Ng; Anissa A Widjaja; Sivakumar Viswanathan; Jinrui Dong; Sonia P Chothani; Stella Lim; Shamini G Shekeran; Jessie Tan; Narelle E McGregor; Emma C Walker; Natalie A Sims; Sebastian Schafer; Stuart A Cook
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.